This timely volume reviews current data on the effects of estrogen on the central nervous system, highlighting clinical aspects of this topic. Experts from the fields of psychiatry, pharmacology, neurology, and geriatrics collaborate to clarify the known risks and benefits of hormone therapy and explore questions that remain to be elucidated. Among the topics discussed:" Preclinical data on estrogen's effects on cognitive performance" The short-lived effects of hormone replacement therapy on cognitive function" Structural and functional brain imaging data regardingestrogen's effects on the central nervous system " Preclinical efforts to develop effective NeuroSERMs for the brain " The effects of estrogen on mood Citing the ongoing confusion over the risks and benefits of estrogen therapy, the contributors emphasize the need for additional research on medication, doses, preparations, methods of administration, alternative therapies, and supplements. This volume educates researchers, clinicians, and students on the current knowledge-including the effects of estrogen on mood, cognition, and brain metabolism-and provides guidelines for clinical practice and future research. Contributors: Roberta Diaz Brinton, Ph.D., University of Southern California; Cheri L. Geist, B.A., David Geffen School of Medicine, University of California at Los Angeles; Robert B. Gibbs, Ph.D., University of Pittsburgh School of Pharmacy; Eva Hogervorst, Ph.D., University of Loughborough and University of Oxford; Pauline M. Maki, Ph.D., Neuropsychiatric Institute, University of Illinois-Chicago; Peter J. Schmidt, M.D., National Institute of Mental Health; Daniel H. S. Silverman, M.D., Ph.D., David Geffen School of Medicine, University of California at Los Angeles; Katherine E. Williams, M.D., Stanford University School of Medicine; Kristine Yaffe, M.D., University of California, San Francisco, and San Francisco VA Medical Center; Laurel N. Zappert, B.A., Stanford University School of Medicine; Liqin Zhao, Ph.D., University of Southern California
"Sinopsis" puede pertenecer a otra edición de este libro.
Natalie L. Rasgon, M.D., Ph.D., is an associate professor in the departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at the Stanford University School of Medicine, where she is director for the Behavioral Neuroendocrinology and the Women's Wellness Programs.
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: Nilbog Books, Portland, ME, Estados Unidos de America
Hardcover. Condición: New. Estado de la sobrecubierta: None Issued. First Edition. This is a New and Unread copy of the first edition. Nº de ref. del artículo: 024292
Cantidad disponible: 1 disponibles
Librería: Conover Books, Martinsville, VA, Estados Unidos de America
Pictorial Boards. Condición: Very Good. No Jacket. First Edition. Ex-library with the usual library markings (if not for the library markings this copy would be graded in fine condition); overall a nice used copy! Yellosw and blue boards with white, red, and black lettering. 170 informative and educational pages nicely enhanced by black and white illustrations! "This timely volume reviews current data on the effects of estrogen on the central nervous system, highlighting clinical aspects of this topic. Experts from the fields of psychiatry, pharmacology, neurology, and geriatrics collaborate to clarify the known risks and benefits of hormone therapy and explore questions that remain to be elucidated." Size: 8vo - over 7¾" - 9¾" tall. Ex-Library. Nº de ref. del artículo: 049437
Cantidad disponible: 1 disponibles
Librería: SHIMEDIA, Brooklyn, NY, Estados Unidos de America
Condición: New. Satisfaction Guaranteed or your money back. Nº de ref. del artículo: 0801882826
Cantidad disponible: 1 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 4117674-n
Cantidad disponible: 9 disponibles
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Hardcover. Condición: new. Hardcover. This timely volume reviews current data on the effects of estrogen on the central nervous system, highlighting clinical aspects of this topic. Experts from the fields of psychiatry, pharmacology, neurology, and geriatrics collaborate to clarify the known risks and benefits of hormone therapy and explore questions that remain to be elucidated. Among the topics discussed:" Preclinical data on estrogen's effects on cognitive performance" The short-lived effects of hormone replacement therapy on cognitive function" Structural and functional brain imaging data regardingestrogen's effects on the central nervous system " Preclinical efforts to develop effective NeuroSERMs for the brain " The effects of estrogen on mood Citing the ongoing confusion over the risks and benefits of estrogen therapy, the contributors emphasize the need for additional research on medication, doses, preparations, methods of administration, alternative therapies, and supplements. This volume educates researchers, clinicians, and students on the current knowledge-including the effects of estrogen on mood, cognition, and brain metabolism-and provides guidelines for clinical practice and future research.Contributors: Roberta Diaz Brinton, Ph.D., University of Southern California; Cheri L. Geist, B.A., David Geffen School of Medicine, University of California at Los Angeles; Robert B. Gibbs, Ph.D., University of Pittsburgh School of Pharmacy; Eva Hogervorst, Ph.D., University of Loughborough and University of Oxford; Pauline M. Maki, Ph.D., Neuropsychiatric Institute, University of Illinois-Chicago; Peter J. Schmidt, M.D., National Institute of Mental Health; Daniel H. S. Silverman, M.D., Ph.D., David Geffen School of Medicine, University of California at Los Angeles; Katherine E. Williams, M.D., Stanford University School of Medicine; Kristine Yaffe, M.D., University of California, San Francisco, and San Francisco VA Medical Center; Laurel N. Zappert, B.A., Stanford University School of Medicine; Liqin Zhao, Ph.D., University of Southern California D., University of Southern California Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9780801882821
Cantidad disponible: 1 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 4117674
Cantidad disponible: 9 disponibles
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condición: New. 2006. 1st Edition. Hardcover. . . . . . Nº de ref. del artículo: V9780801882821
Cantidad disponible: 2 disponibles
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
Condición: New. 2006. 1st Edition. Hardcover. . . . . . Books ship from the US and Ireland. Nº de ref. del artículo: V9780801882821
Cantidad disponible: 2 disponibles
Librería: moluna, Greven, Alemania
Condición: New. Über den AutorNatalie L. Rasgon, M.D., Ph.D., is an associate professor in the departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at the Stanford University School of Medicine, where she is di. Nº de ref. del artículo: 898718492
Cantidad disponible: 5 disponibles
Librería: AussieBookSeller, Truganina, VIC, Australia
Hardcover. Condición: new. Hardcover. This timely volume reviews current data on the effects of estrogen on the central nervous system, highlighting clinical aspects of this topic. Experts from the fields of psychiatry, pharmacology, neurology, and geriatrics collaborate to clarify the known risks and benefits of hormone therapy and explore questions that remain to be elucidated. Among the topics discussed:" Preclinical data on estrogen's effects on cognitive performance" The short-lived effects of hormone replacement therapy on cognitive function" Structural and functional brain imaging data regardingestrogen's effects on the central nervous system " Preclinical efforts to develop effective NeuroSERMs for the brain " The effects of estrogen on mood Citing the ongoing confusion over the risks and benefits of estrogen therapy, the contributors emphasize the need for additional research on medication, doses, preparations, methods of administration, alternative therapies, and supplements. This volume educates researchers, clinicians, and students on the current knowledge-including the effects of estrogen on mood, cognition, and brain metabolism-and provides guidelines for clinical practice and future research.Contributors: Roberta Diaz Brinton, Ph.D., University of Southern California; Cheri L. Geist, B.A., David Geffen School of Medicine, University of California at Los Angeles; Robert B. Gibbs, Ph.D., University of Pittsburgh School of Pharmacy; Eva Hogervorst, Ph.D., University of Loughborough and University of Oxford; Pauline M. Maki, Ph.D., Neuropsychiatric Institute, University of Illinois-Chicago; Peter J. Schmidt, M.D., National Institute of Mental Health; Daniel H. S. Silverman, M.D., Ph.D., David Geffen School of Medicine, University of California at Los Angeles; Katherine E. Williams, M.D., Stanford University School of Medicine; Kristine Yaffe, M.D., University of California, San Francisco, and San Francisco VA Medical Center; Laurel N. Zappert, B.A., Stanford University School of Medicine; Liqin Zhao, Ph.D., University of Southern California D., University of Southern California Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Nº de ref. del artículo: 9780801882821
Cantidad disponible: 1 disponibles